| Publikationstyp: | Beitrag in wissenschaftlicher Zeitschrift |
| Art der Begutachtung: | Peer review (Publikation) |
| Titel: | A novel 99mTc labelling strategy for the development of silica based particles for medical applications |
| Autor/-in: | Wuillemin, Michel A. Stuber, Wanda T. Fox, Thomas Reber, Michael J. Brühwiler, Dominik Alberto, Roger Braband, Henrik |
| DOI: | 10.1039/C3DT53019A |
| Erschienen in: | Dalton Transactions |
| Band(Heft): | 43 |
| Heft: | 11 |
| Seite(n): | 4260 |
| Seiten bis: | 4263 |
| Erscheinungsdatum: | 2014 |
| Verlag / Hrsg. Institution: | Royal Society of Chemistry |
| ISSN: | 1477-9226 1477-9235 |
| Sprache: | Englisch |
| Schlagwörter: | Technetium; Mesoporous; Radioimaging; Silica |
| Fachgebiet (DDC): | 540: Chemie 610: Medizin und Gesundheit |
| Zusammenfassung: | The reaction of high-valent fac-{99mTcO3}+ complexes with alkenes ((3+2)-cycloaddition) has been used to develop a novel labelling procedure for silica based particles. This strategy can help to gain more detailed in vivo data of mesoporous silica by non-invasive radioimaging in the future. By applying norbornene as a coupling unit the (3+2)-cycloaddition reaction proceeds stereoselectively and with high reaction rates. |
| URI: | https://digitalcollection.zhaw.ch/handle/11475/2607 |
| Volltext Version: | Publizierte Version |
| Lizenz (gemäss Verlagsvertrag): | Lizenz gemäss Verlagsvertrag |
| Departement: | Life Sciences und Facility Management |
| Organisationseinheit: | Institut für Chemie und Biotechnologie (ICBT) |
| Publiziert im Rahmen des ZHAW-Projekts: | Molecular Alignment Chips (MACs) |
| Enthalten in den Sammlungen: | Publikationen Life Sciences und Facility Management |
Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.
Zur Langanzeige
Wuillemin, M. A., Stuber, W. T., Fox, T., Reber, M. J., Brühwiler, D., Alberto, R., & Braband, H. (2014). A novel 99mTc labelling strategy for the development of silica based particles for medical applications. Dalton Transactions, 43(11), 4260–4263. https://doi.org/10.1039/C3DT53019A
Wuillemin, M.A. et al. (2014) ‘A novel 99mTc labelling strategy for the development of silica based particles for medical applications’, Dalton Transactions, 43(11), pp. 4260–4263. Available at: https://doi.org/10.1039/C3DT53019A.
M. A. Wuillemin et al., “A novel 99mTc labelling strategy for the development of silica based particles for medical applications,” Dalton Transactions, vol. 43, no. 11, pp. 4260–4263, 2014, doi: 10.1039/C3DT53019A.
WUILLEMIN, Michel A., Wanda T. STUBER, Thomas FOX, Michael J. REBER, Dominik BRÜHWILER, Roger ALBERTO und Henrik BRABAND, 2014. A novel 99mTc labelling strategy for the development of silica based particles for medical applications. Dalton Transactions. 2014. Bd. 43, Nr. 11, S. 4260–4263. DOI 10.1039/C3DT53019A
Wuillemin, Michel A., Wanda T. Stuber, Thomas Fox, Michael J. Reber, Dominik Brühwiler, Roger Alberto, and Henrik Braband. 2014. “A Novel 99mTc Labelling Strategy for the Development of Silica Based Particles for Medical Applications.” Dalton Transactions 43 (11): 4260–63. https://doi.org/10.1039/C3DT53019A.
Wuillemin, Michel A., et al. “A Novel 99mTc Labelling Strategy for the Development of Silica Based Particles for Medical Applications.” Dalton Transactions, vol. 43, no. 11, 2014, pp. 4260–63, https://doi.org/10.1039/C3DT53019A.
Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.